SMS Pharmaceuticals
Sms Pharmaceuticals Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in SMS Pharmaceuticals
Start SIPSms Pharmaceuticals Investment Rating
-
Master Rating:
-
Sms Pharmaceuticals has an operating revenue of Rs. 433.54 Cr. on a trailing 12-month basis. An annual revenue de-growth of -7% needs improvement, Pre-tax margin of 13% is healthy, ROE of 13% is good. The company has a reasonable debt to equity of 32%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 12 which is a POOR score indicating inconsistency in earnings, a RS Rating of 11 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 84 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 149 | 159 | 64 | 61 |
| Operating Expenses Qtr Cr | 131 | 146 | 65 | 65 |
| Operating Profit Qtr Cr | 18 | 14 | 0 | -4 |
| Depreciation Qtr Cr | 8 | 8 | 8 | 8 |
| Interest Qtr Cr | 6 | 5 | 5 | 4 |
| Tax Qtr Cr | 1 | 0 | -3 | -25 |
| Net Profit Qtr Cr | 5 | 1 | -10 | 9 |
Sms Pharmaceuticals Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- 63.8
- 50 Day
- 69.2
- 100 Day
- 74.64
- 200 Day
- 82.56
- 20 Day
- 64.89
- 50 Day
- 69.98
- 100 Day
- 77.09
- 200 Day
- 80.99
Sms Pharmaceuticals Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 58.22 |
| Second Resistance | 59.94 |
| Third Resistance | 61.67 |
| RSI | 29.54 |
| MFI | 35.53 |
| MACD Single Line | -2.76 |
| MACD | -3.51 |
| Support | |
|---|---|
| First Resistance | 54.77 |
| Second Resistance | 53.04 |
| Third Resistance | 51.32 |
Sms Pharmaceuticals Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 162,450 | 11,135,948 | 68.55 |
| Week | 123,319 | 7,685,209 | 62.32 |
| 1 Month | 91,544 | 7,374,765 | 80.56 |
| 6 Month | 74,281 | 4,688,600 | 63.12 |
Sms Pharmaceuticals Result Highlights
SMS Pharmaceuticals Synopsis
NSE-Medical-Generic Drugs
Sms Pharmaceuticals is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 519.87 Cr. and Equity Capital is Rs. 8.47 Cr. for the Year ended 31/03/2022. SMS Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 14/12/1987 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24239TG1987PLC008066 and registration number is 008066.| Market Cap | 493 |
| Sales | 434 |
| Shares in Float | 3.05 |
| No of funds | 3 |
| Yield | 0.53 |
| Book Value | 0.99 |
| U/D Vol ratio | 0.6 |
| LTDebt / Equity | 30 |
| Alpha | -0.16 |
| Beta | 0.9 |
SMS Pharmaceuticals
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 64.17% | 64.17% | 64.17% | |
| Mutual Funds | ||||
| Foreign Portfolio Investors | 0.59% | 0.59% | 0.63% | |
| Individual Investors | 28.82% | 28.84% | 29.65% | |
| Others | 6.42% | 6.4% | 5.55% |
SMS Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mr. Ramesh Babu Potluri | Chairman & Managing Director |
| Mr. Vamsi Krishna Potluri | Executive Director |
| Mr. Sarath Kumar Pakalapati | Independent Director |
| Mr. Sharvan Kudaravalli | Independent Director |
| Mr. Sarvepalli Srinivas | Independent Director |
| Dr.(Mrs.) Neelaveni Thummala | Independent Director |
Sms Pharmaceuticals Forecast
Price Estimates
SMS Pharmaceuticals FAQs
What is Share Price of SMS Pharmaceuticals ?
SMS Pharmaceuticals share price is ₹58 As on 31 March, 2023 | 21:09
What is the Market Cap of SMS Pharmaceuticals ?
The Market Cap of SMS Pharmaceuticals is ₹493.1 Cr As on 31 March, 2023 | 21:09
What is the P/E ratio of SMS Pharmaceuticals ?
The P/E ratio of SMS Pharmaceuticals is -101.9 As on 31 March, 2023 | 21:09
What is the PB ratio of SMS Pharmaceuticals ?
The PB ratio of SMS Pharmaceuticals is 1 As on 31 March, 2023 | 21:09